Your browser doesn't support javascript.
loading
Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer.
Csizmarik, Anita; Keresztes, Dávid; Nagy, Nikolett; Bracht, Thilo; Sitek, Barbara; Witzke, Kathrin; Puhr, Martin; Tornyi, Ilona; Lázár, József; Takács, László; Kramer, Gero; Sevcenco, Sabina; Maj-Hes, Agnieszka; Jurányi, Zsolt; Hadaschik, Boris; Nyirády, Péter; Szarvas, Tibor.
Afiliação
  • Csizmarik A; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Keresztes D; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Nagy N; Department of Urology, Semmelweis University, Budapest, Hungary.
  • Bracht T; Medizinisches Proteom Center, Ruhr University Bochum, Bochum, Germany.
  • Sitek B; Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, Germany.
  • Witzke K; Center for Protein Diagnostics, Medical Proteome Analysis, Ruhr-University Bochum, Bochum, Germany.
  • Puhr M; Medizinisches Proteom Center, Ruhr University Bochum, Bochum, Germany.
  • Tornyi I; Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, Germany.
  • Lázár J; Center for Protein Diagnostics, Medical Proteome Analysis, Ruhr-University Bochum, Bochum, Germany.
  • Takács L; Medizinisches Proteom Center, Ruhr University Bochum, Bochum, Germany.
  • Kramer G; Center for Protein Diagnostics, Medical Proteome Analysis, Ruhr-University Bochum, Bochum, Germany.
  • Sevcenco S; Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
  • Maj-Hes A; Department of Human Genetics, University of Debrecen, Debrecen, Hungary.
  • Jurányi Z; Biosystems International Kft, Debrecen, Hungary.
  • Hadaschik B; Department of Human Genetics, University of Debrecen, Debrecen, Hungary.
  • Nyirády P; Biosystems International Kft, Debrecen, Hungary.
  • Szarvas T; Department of Urology, Medical University of Vienna, Vienna, Austria.
Int J Cancer ; 151(8): 1405-1419, 2022 10 15.
Article em En | MEDLINE | ID: mdl-35689436
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Moléculas de Adesão Celular Neuronais / Resistencia a Medicamentos Antineoplásicos / Molécula de Adesão de Leucócito Ativado / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Moléculas de Adesão Celular Neuronais / Resistencia a Medicamentos Antineoplásicos / Molécula de Adesão de Leucócito Ativado / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article